Phase III Clinical Trial of Y-2 Sublingual Tablets in the Treatment of Acute Ischemic Stroke
Clinical trial NCT04950920 · COMPLETED
Trial details
- NCT number
- NCT04950920
- Sponsor
- Peking University Third Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-28
- Primary completion
- 2022-08-10
- Enrollment
- 914
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.